Caplacizumab
Products Caplacizumab was approved in many countries in 2019 as a powder and solvent for solution for injection (Cablivi). Structure and properties Caplacizumab is a humanized, bivalent nanobody (single-domain antibody) produced by biotechnological methods. It consists of two building blocks (PMP12A2hum1) linked by a 3-alanine linker. Effects Caplacizumab (ATC B01AX07) binds to the A1 domain … Caplacizumab
